Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Ipamorelin structure

Ipamorelin

Growth Hormone
Phase 2 Research
50%
Low Risk
1/5

Dosing Protocol

Typical Dose 200 mcg
Range 100 - 300 mcg
Maintenance 200 mcg 2-3x daily

Pharmacokinetics

Half-Life 2.0 hrs
Onset 10 min
Peak 30 min
Duration 3.0 hrs
Bioavailability 95%
Primary Route Subcutaneous

Administration

Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Morning

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 21 days refrigerated
Vial Sizes 5 mg

Special Instructions

Most selective GHRP with minimal hunger/cortisol effects. Best combined with CJC-1295.